beta
/A CD79b Targeting ADC with Superior Anti-Tumor Activity and Safety Resulting in Significantly Improved Therapeutic Index (TI): Safe and Efficacious CD79b ADC

Reviews

Join the dialogue

Submit a peer review to improve the scientific record

Summary